Clinical Trial

Accelerated TMS for Perinatal Depression

Study acronym: PAiNT
Recruiting
View on ClinicalTrials.gov →
Summary
We are studying a treatment for depression called accelerated Transcranial Magnetic Stimulation (TMS) among pregnant and postpartum individuals. TMS is a focal, non-invasive form of brain stimulation that is cleared by the Food and Drug Administration for depression. Typically, traditional TMS involves daily treatments for 6-8 weeks. In this study, we will offer an accelerated form of TMS that involves multiple daily treatments for 5 days.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-05; most recent amendment 2025-09-03.
Status change: Not Yet Recruiting → Recruiting 2025-08-11
Trial Details
NCT Number NCT06968390
Lead Sponsor Brigham and Women's Hospital
Conditions Perinatal Depression, Post Partum Depression, Major Depressive Disorder
Enrollment 24 participants
Start Date 2025-08-05
Primary Completion 2026-11-30 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-09